伤口治疗

Clinical Summary: The Wound Treatment collection at EMIS Asia offers a curated range of advanced wound care products including foams, alginates, hydrocolloids, hydrofibers, and antimicrobial dressings for Singapore healthcare professionals and home care providers. Products are selected for compliance with CE MDR 2017/745 and ISO 13485:2016 quality management standards, meeting the clinical demands of acute and chronic wound management across Singapore hospitals, polyclinics, and community nursing settings. This buyer's guide assists clinicians and procurement teams in selecting the appropriate dressing modality based on wound type, exudate level, infection status, and care setting.

Wound Treatment Product Overview

Optimal wound management requires matching the dressing to the wound's biological state and exudate profile at each phase of healing. The proliferative and remodelling phases of wound healing depend on a moist, thermally stable, and microbiologically controlled wound environment — a principle established by Winter (1962) and now codified in evidence-based guidelines from the European Wound Management Association (EWMA) and the World Union of Wound Healing Societies (WUWHS). Selecting the correct dressing category reduces healing time, lowers infection risk, minimises patient discomfort, and controls overall care costs.

EMIS Asia stocks advanced interactive and bioactive wound dressings used across Singapore's acute hospitals, community health facilities, home care agencies, and specialist wound care clinics. All products in this collection meet CE marking requirements under EU MDR 2017/745, and are supplied through validated documentation processes to support Health Sciences Authority (HSA) Singapore procurement compliance and Ministry of Health (MOH) institutional purchasing frameworks.

Wound Dressing Selection Guide

Wound Type / Condition Exudate Level Recommended Dressing Category Clinical Rationale
Venous leg ulcer (clean) Moderate–Heavy Foam or Hydrofiber High absorbency prevents periwound maceration; maintains moist healing environment per EWMA guidelines
Diabetic foot ulcer (infected) Moderate–Heavy Alginate Silver / Antimicrobial foam Ionic silver delivers broad-spectrum antimicrobial action including MRSA; alginate manages exudate and fills cavity
Pressure injury Stage 2–4 Low–Moderate Hydrocolloid or Foam Conforms to body contours; facilitates autolytic debridement; reduces shear forces at bony prominences
Post-surgical / acute wound Low–Moderate Film dressing or Non-adherent pad Transparent film allows visual inspection without dressing removal; maintains sterile environment
Partial-thickness burn Moderate–Heavy Alginate Silver or Hydrofiber Haemostatic and antimicrobial properties; supports re-epithelialisation; recommended by British Burns Association (BBA)
Cavity wound / sinus tract Moderate–Heavy Alginate rope or Hydrofiber rope Conformable fiber fills dead space and wicks exudate; prevents premature surface closure over cavity
Sloughy/necrotic wound Low Hydrogel under secondary dressing Rehydrates necrotic tissue; facilitates autolytic debridement; avoids sharp debridement in community settings

Clinical Indications for Advanced Wound Dressings

  • Chronic non-healing wounds: Venous, arterial, and mixed-aetiology leg ulcers requiring moist wound healing and exudate management over extended treatment periods in Singapore's ageing population
  • Diabetic foot ulcers (DFU): Neuropathic or ischaemic ulcers with moderate-to-heavy exudate and elevated infection risk; Singapore has one of Asia's highest diabetes prevalence rates, driving demand for advanced DFU dressings
  • Pressure injuries (Stage 2–4): Skin breakdown in immobile patients requiring absorbent, low-trauma dressings that reduce shear and friction at bony prominences
  • Post-operative wounds: Surgical incisions, dehisced wounds, and drain sites requiring sterile secondary coverage and exudate containment in both acute and home care settings
  • Partial-thickness burns and donor sites: Thermal injuries requiring moist, antimicrobial coverage to support re-epithelialisation and minimise scarring
  • Fungating tumour wounds: Malignant wounds requiring odour management, high absorbency, and atraumatic dressing removal in palliative care contexts

Frequently Asked Questions

Q: How do I select between foam, alginate, and hydrocolloid dressings for the same patient?
A: Selection is governed primarily by exudate volume and wound infection status. Foam dressings are preferred for moderate-to-heavy non-infected exudate; alginates (with or without silver) for infected or heavily exuding wounds requiring haemostatic properties; hydrocolloids for low-to-moderate exudate wounds needing autolytic debridement. The EWMA TIME framework — Tissue, Infection, Moisture, Edge — provides a validated decision-making model applicable across wound types.

Q: When is an antimicrobial dressing clinically indicated versus a standard dressing?
A: Antimicrobial dressings (silver, iodine, or PHMB-based) are indicated when two or more clinical signs of localised infection are present: erythema, warmth, oedema, purulent exudate, or increased pain at the wound site. They are also appropriate for wounds with high biofilm risk, including chronic wounds not progressing despite optimised local and systemic management over 2–4 weeks.

Q: What is the recommended dressing change frequency for advanced wound dressings?
A: Change frequency depends on exudate level and dressing capacity. Foam dressings may remain in place 3–7 days if not saturated; alginates are changed when fully converted to gel (typically every 1–3 days for high-exudate wounds); hydrocolloids can remain up to 7 days. Always change earlier if leakage, periwound maceration, or clinical deterioration occurs.

Q: Are EMIS Asia wound care products compliant with Singapore healthcare procurement requirements?
A: Products in the EMIS Asia wound treatment catalogue carry CE marking under EU MDR 2017/745 and comply with ISO 13485:2016 quality management requirements. Institutions subject to HSA Singapore or MOH procurement frameworks can request product technical files, Declaration of Conformity documents, and batch traceability records on request. EMIS Asia supports institutional formulary listing processes for Singapore public and private healthcare groups.

Q: Can wound dressings be purchased for home care use in Singapore?
A: Yes. EMIS Asia supplies both institutional and home care clients in Singapore. Dressings can be prescribed through general practitioners, wound care nurses, community nurses, or specialist clinics. Correct dressing selection, application guidance, and change frequency protocols are available through EMIS Asia's clinical support team for patients transitioning from acute to home care settings.